Skip to main content
. 2021 May-Jun;37(3):879–884. doi: 10.12669/pjms.37.3.3638

Table-I.

Comparative analysis on general data of patients in experimental and control groups ( ±S) n=30

Indexes Experimental group Control group t/χ2 p
Male (number, %) 17(57%) 19(63%) 0.28 0.60
Age 41.50±9.07 42.37±8.83 0.38 0.71
Tumor site
Cervical segment 12 10 0.29 0.59
Thoracic segment 14 15 0.07 0.79
Lumbar segment 4 5 0.13 0.72
KPS score 68.54±12.27 69.29±13.10 0.23 0.82
SF-36 score 47.74±3.35 49.13±5.24 1.22 0.23

p>0.05.